Ferozsons Laboratories Ltd

KAR:FEROZHealth TechnologyPSX:ALLSHRPSX:KMIALLSHR

Rs 334.35−0.26%LiveIn session · ≈ AED 4.44 · Market cap $52.17M

FEROZ · Income statement · TradingHolo

PKR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	6.2	8.9	9.3	11.5	15.9	18.9	22.7	+20.3%
Cost of revenue	4.0	5.4	5.5	7.4	9.7	11.2	12.8	+13.9%
Gross profit	2.2	3.5	3.8	4.1	6.2	7.6	9.9	+29.6%
Operating expenses	1.6	2.0	2.6	3.3	4.6	5.7	7.3	+28.4%
Operating income	0.6	1.4	1.2	0.8	1.6	1.9	2.6	+33.2%
Interest expense	0.0	0.0	0.1	0.3	0.7	0.6	0.4	−30.4%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Pre-tax income	0.6	1.6	1.2	0.3	1.1	1.5	2.0	+31.8%
Income tax	0.2	0.3	0.4	0.0	0.4	0.6	0.8	+38.3%
Net income	0.4	1.2	0.7	0.3	0.7	0.8	0.9	+21.3%
EPS, basic (per share)	9.59	27.00	16.90	6.24	15.72	17.86	21.66	+21.3%
EPS, diluted (per share)	9.59	27.00	16.90	6.24	15.72	17.86	21.66	+21.3%
EBITDA	0.9	1.8	1.7	1.3	2.1	2.9	3.6	+25.8%
Depreciation & amortization	0.4	0.4	0.4	0.5	0.5	0.9	1.0	+10.8%
Weighted average shares (shares)	43,469,086	43,469,069	43,469,069	43,469,052	43,469,052	43,469,052	—	—
Weighted average diluted shares (shares)	43,469,086	43,469,069	43,469,069	43,469,052	43,469,052	43,469,052	—	—
Gross margin	35.4%	39.1%	40.8%	35.8%	39.1%	40.5%	43.6%	+3.1 pts
Operating margin	8.9%	16.3%	13.2%	7.2%	9.9%	10.2%	11.3%	+1.1 pts
Net margin	6.7%	13.2%	7.9%	2.4%	4.3%	4.1%	4.2%	+0.0 pts

PKR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-03-31 and uses four consecutive reported quarters.